Free Newsletter
Lonza starts thinking lean with Raman
For contract manufacturer Lonza, raw material QC processes--particularly the sampling required in material identification testing--became a target of lean thinking. The contract manufacturer conducted a study of spectroscopic technologies--Raman, near-infrared, and Fourier Transform infrared portable devices--to speed its lab-based analysis while maintaining ID accuracy.
Of the spectroscopic techniques studied, Raman and NIR outperformed FTIR for accuracy and sensitivity, according to PharmaManufacturing.com. And although the outperformers both penetrate multiple container types, Raman excelled by proving itself with poly bags, HDPE bottles, and clear and amber glass containers. NIR worked well with poly bags, but not bottles.
Lonza now has the Raman units in place at five of its biopharma sites. And thanks to product commonality across them, the company has so far harmonized specs on 10 raw materials.
- here's the article
Related Articles:
Simulation smartens scheduling for Lonza
Cost concerns stall, drive contract services
Lonza steps up for GSK and Genmab
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: